Kandilli, B. Et Al. 2021. Orally disintegrating tablet containing carbamazepine and levetiracetam: formulation and in vitro and in vivo characterization. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , vol.47, no.7 , 1153-1165.

Kandilli, B., UĞUR KAPLAN, A. B., ÇETİN, M., Taspinar, N., Genc, S., YENİ, Y., ... Ertugrul, M. S.(2021). Orally disintegrating tablet containing carbamazepine and levetiracetam: formulation and in vitro and in vivo characterization. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , vol.47, no.7, 1153-1165.

Kandilli, Büşra Et Al. "Orally disintegrating tablet containing carbamazepine and levetiracetam: formulation and in vitro and in vivo characterization," DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , vol.47, no.7, 1153-1165, 2021

Kandilli, Büşra Et Al. "Orally disintegrating tablet containing carbamazepine and levetiracetam: formulation and in vitro and in vivo characterization." DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , vol.47, no.7, pp.1153-1165, 2021

Kandilli, B. Et Al. (2021) . "Orally disintegrating tablet containing carbamazepine and levetiracetam: formulation and in vitro and in vivo characterization." DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , vol.47, no.7, pp.1153-1165.

@article{article, author={Büşra KANDİLLİ Et Al. }, title={Orally disintegrating tablet containing carbamazepine and levetiracetam: formulation and in vitro and in vivo characterization}, journal={DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY}, year=2021, pages={1153-1165} }